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Background: Between the 1970s and 2000 mortality in most of Latin America showed favorable trends for some
common cancer sites, including stomach and male lung cancer. However, major concerns were related to mortality
patterns from other cancers, particularly in women. We provide an up-to-date picture of patterns and trends in cancer
mortality in Latin America.
Methods:We analyzed data from the World Health Organization mortality database in 2005–2009 for 20 cancer sites in
11 Latin American countries and, for comparative purposes, in the USA and Canada. We computed age-standardized
(world population) rates (per 100 000 person-year) and provided an overview of trends since 1980 using joinpoint regres-
sion models.
Results: Cancer mortality from some common cancers (including colorectum and lung) is still comparatively low in Latin
America, and decreasing trends continue for other cancer sites (including stomach, uterus, male lung cancers) in several
countries. However, there were upward trends for colorectal cancer mortality for both sexes, and for lung and breast
cancer mortality in women from most countries. During the last decade, lung cancer mortality in women rose by 1%–3%
per year in all Latin American countries except Mexico and Costa Rica, whereas rises of about 1% were registered for
breast cancer in Brazil, Colombia and Venezuela. Moreover, high mortality from cancer of the cervix uteri was recorded in
most countries, with rates over 13/100 000 women in Cuba and Venezuela. In men, upward trends were registered for
prostate cancer mortality in Brazil and Colombia, but also in Cuba, where the rate in 2005–2009 was more than twice that
of the USA (23.6 versus 10/100 000).
Conclusions: Tobacco control, efﬁcient screening programs, early cancer detection and widespread access to treat-
ments continue to be a major priority for cancer prevention in most Latin American countries.
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introduction
Between the 1970s and 2000, cancer mortality in Latin America
showed favorable trends for some common cancer sites, including
stomach in both sexes, lung and other tobacco-related cancers in
men. In addition, mortality from some cancers (including colo-
rectal and lung cancers) remained appreciably lower than in
North America [1]. However, despite some declines, most coun-
tries still showed very high mortality rates for cancer of the uterus
[2] and female lung, and breast cancers have been increasing in
several countries. Mortality from selected neoplasms amenable to
treatment, including testicular cancer and leukemias, also
showed unfavourable trends in the last decades of the 1990s in
some areas of the continent [2, 3], though promising trends
were recently observed for Hodgkin’s lymphoma [4].
We updated mortality data available from major countries of
the Americas up to the year 2010, including, for comparative
purposes, the United States of America (USA) and Canada. We
also provided an overview of cancer mortality trends in the last
30 years.
materials andmethods
Certiﬁed deaths for 20 selected cancer sites and total cancer mortality for the
calendar period 1980–2010 were derived from the World Health Organization
(WHO) database [5]. Eleven Latin American countries were considered, i.e.
Argentina, Brazil, Chile, Colombia, Costa Rica, Cuba, Ecuador, Mexico,
Puerto Rico, Uruguay and Venezuela, plus Canada and the USA.
We computed age-standardized rates per 100 000 persons-year at all ages
and truncated at age 35–64 using the direct method, on the basis of the
world standard population [6].
To identify signiﬁcant changes in the linear slope of the trend and to esti-
mate annual percent changes (APC) [7, 8] for each segment, joinpoint re-
gression models were used.
The Appendix (supplementary Text S1, available at Annals of Oncology
online) reports some details related to the methods, in particular on coun-
tries selection, data retrieval and other assumptions made for data analysis.
results
results presentation
Tables 1 (men) and 2 (women) include, for the 20 selected
cancers and all neoplasms, the age-standardized overall mortal-
ity rates per 100 000, and the mean annual number of deaths
between 2005 and 2009 (unless otherwise speciﬁed) in the 13
selected countries.
Figure 1 shows the trends in rates at all ages and truncated
35–64 years, for seven major cancer sites and all neoplasms, in
the 11 Latin American countries considered and the USA for
men and women.
For reasons of brevity, only major cancers were discussed
in the main text and only principal ﬁgures and tables were
reported. Supplementary data are given in Appendix, available
at Annals of Oncology online. In particular, Supplementary
Tables S1 (men) and S2 (women), available at Annals of
Oncology online, give the age-standardized truncated mortality
rates (at age 35–64) and the corresponding mean annual
number of deaths between 2005 and 2009.
Supplementary Figures S1 (S1a–S1g) and S2 (S2a–S2g), avail-
able at Annals of Oncology online, give histograms of geographic
variation of overall and truncated (35–64 years) age-standar-
dized mortality rates for men and women.
Supplementary Table S3, available at Annals of Oncology
online, gives the APC estimated from joinpoint regression models
for all ages and truncated 35–64 years in men and women.
Supplementary Figure S3 (S3a–S3f ), available at Annals of
Oncology online, shows the trends for the cancer sites not
included in Figure 1 nor discussed in our main text due to word
restriction (i.e. oral cavity and pharynx, esophagus, gallbladder,
pancreas, larynx, ovary, testis, bladder, kidney, Hodgkin’s
lymphoma, non-Hodgkin’s lymphoma and multiple myeloma).
all neoplasms (malignant and benign)
We pooled all neoplasms, together both malignant and benign,
including essentially brain cancers which may cause death even
if benign. The highest total cancer mortality rates in men were
observed in Uruguay (177/100 000), Argentina (140) and Cuba
(139) while rates in North America were around 130/100 000.
Rates below 75/100 000 men were registered in Mexico and
Ecuador (Table 1; supplementary Figure S1g, available at Annals
of Oncology online). In women, the highest total cancer mortal-
ity rates were in Uruguay and Cuba (∼100/100 000), Argentina
and Chile (∼92/100 000) and ∼95/100 000 in North America.
Rates below 70/100 000 were registered in Puerto Rico, Mexico
and Ecuador, in Brazil, and the overall cancer mortality rate in
women was 74/100 000 (Table 2; supplementary Figure S1g,
available at Annals of Oncology online). In most countries,
overall cancer mortality tended to decline, particularly in men,
but slight increases were observed in Brazil and Cuba (Figure 1;
supplementary Table S3, available at Annals of Oncology
online).
stomach cancer
Stomach cancer mortality remained appreciably higher in Latin
America compared with North America in both sexes (Tables 1
and 2; supplementary Figure S1a, available at Annals of
Oncology online). In men, the highest rate was in Chile (23/
100 000) while, in most other countries, rates ranged between 10
and 17/100 000. Only Argentina, Mexico, Cuba and Puerto Rico
had rates lower than 10/100 000, but still higher than those in
the USA (2.9/100 000, Table 1). A similar geographical pattern
was seen in women. The highest rate was in Ecuador (10.5/
100 000 women) followed by Colombia, Costa Rica and Chile,
with rates ∼8/100 000, while Argentina, Cuba and Puerto Rico
had rates below 3.5/100 000 (Table 2; supplementary Figure S1a,
available at Annals of Oncology online), still higher than Canada
and USA rates (2 and 1.5/100 000 women, respectively). The
patterns were similar when only middle-aged populations were
considered (supplementary Tables S1–S2 and Figure S2a, avail-
able at Annals of Oncology online).
Mortality from stomach cancer steadily decreased over the
last three decades in all American countries and in both sexes
(Figure 1; supplementary Table S3, available at Annals of
Oncology online) with APC lower than −2% in most countries
since 1990s.
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Table 1. Overall age-standardized (world population) mortality rates per 100 000 men (ﬁrst row) and average annual number of deaths (second row) from selected cancers in 13 selected American
countries during 2005–2009 (unless otherwise speciﬁed)
Cancer site
ICD 10
Oral cavity
and pharynx
Esophagus Stomach Colon and
rectum
Liver Gallbladder Pancreas Larynx Lung Bone Prostate Testis Bladder Kidney HL NHL MM Leukemias All
neoplasms
C00–C14 C15 C16 C17–C21,
C26
C22.0–C22.7 C23–C24 C25 C32 C33–
C34
C40–
C41
C61 C62 C67 C64–C66,
C68
C81 C82–C85,
C96
C88,
C90
C91–C95 C00–D48
Argentina 2.84 5.75 8.25 15.76 0.60 2.09 7.90 3.61 29.81 0.88 14.76 0.76 4.19 4.85 0.41 3.43 1.28 4.38 140.26
597 1296 1856 3654 129 480 1779 769 6492 189 3830 160 1011 1060 88 753 287 954 31819
Brazil 5.91 6.63 10.17 8.47 1.39 1.04 3.92 3.70 15.88 0.99 13.39 0.26 2.30 1.71 0.28 2.34 1.23 3.42 104.88
4848 5369 8287 6987 1131 853 3179 2981 12667 862 11409 261 1913 1389 253 1985 987 2992 86577
Chile 1.58 4.78 23.09 9.14 2.31 5.51 4.85 1.31 17.30 0.77 16.58 1.00 2.62 4.20 0.26 3.35 2.29 3.60 125.32
137 435 2064 833 198 493 431 116 1519 66 1614 92 245 373 22 303 201 314 11333
Colombia 1.80 2.87 16.67 6.97 1.47 1.36 3.28 2.03 14.44 0.80 14.20 0.36 1.59 1.25 0.44 2.87 1.13 4.29 97.93
298 463 2744 1162 238 221 533 325 2323 145 2350 78 259 209 81 506 183 829 16412
Costa Rica 2.59 1.87 17.22 8.37 2.85 0.98 3.94 1.64 7.82 0.67 14.40 0.48 1.95 1.70 0.68 3.69 1.77 4.10 96.86
50 36 346 169 56 18 77 32 154 14 315 12 40 33 13 74 33 87 1981
Cuba 5.72 5.67 5.93 10.20 0.98 0.63 4.59 7.45 38.10 1.29 23.55 0.22 4.06 1.69 1.01 3.19 1.91 4.13 139.02
458 447 501 905 79 53 385 603 3173 96 2364 16 374 133 75 241 156 301 11872
Ecuador 0.92 1.24 15.48 3.97 1.04 1.13 2.37 0.61 6.35 0.76 11.63 0.35 0.72 1.17 0.41 2.41 0.69 3.82 70.54
53 72 895 234 58 63 135 36 373 47 729 23 44 65 24 140 37 249 4197
Mexico 1.43 1.51 6.45 4.76 1.95 1.17 3.74 1.60 10.30 0.72 10.63 0.68 1.25 2.30 0.53 2.52 1.00 3.89 74.33
624 656 2864 2103 849 516 1609 690 4471 347 4913 383 560 993 252 1158 424 1980 33500
Puerto Rico
(2005–2007)
4.07 3.86 4.73 13.03 2.28 0.29 3.89 2.04 13.47 0.57 14.36 0.27 1.99 1.93 0.53 3.83 2.11 3.77 99.28
105 101 143 359 59 8 106 54 366 14 513 5 63 49 11 102 57 101 2820
Uruguay
(2007–2009)
4.89 7.16 10.42 18.91 1.90 2.26 9.15 4.59 43.19 0.11 20.38 0.45 5.88 5.97 0.55 4.46 2.16 4.52 177.06
104 169 248 480 43 55 213 103 983 2 607 8 158 137 11 102 51 103 4295
Venezuela
(2005–2007)
2.22 1.94 11.37 6.43 1.23 0.92 3.30 2.90 17.20 0.85 18.72 0.33 1.62 1.96 0.64 2.80 1.22 3.53 99.82
226 195 1145 660 125 93 335 287 1734 101 1822 45 161 204 73 306 123 427 10254
Canada 2.79 4.63 4.18 16.56 3.25 0.62 6.71 1.31 37.30 0.41 10.73 0.18 3.95 3.68 0.30 5.00 2.36 4.86 130.83
729 1240 1186 4755 873 179 1846 356 10369 82 3649 34 1246 1030 72 1393 676 1334 37160
USA 2.51 4.90 2.89 11.98 3.49 0.53 7.46 1.33 38.96 0.42 10.00 0.20 3.62 3.70 0.34 4.64 2.49 5.40 128.24
5401 10792 6713 28209 7535 1290 17045 2936 88834 767 28587 355 9616 8410 698 11084 6002 12539 300300
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Figure 1. Joinpoint analysis for age-standardized (world population) death rates from major cancer sites (stomach, colon and rectum, lung, breast, uterus,
prostate, and leukemias and all neoplasms) in 11 Latin American countries and the USA between 1980 and 2010. All-ages, men (open square) and women
(open circle). Truncated 35–64 years, men (ﬁlled square) and women (ﬁlled circle).
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Table 2. Overall age-standardized (world population) mortality rates per 100 000 women (ﬁrst row) and average annual number of deaths (second row) from selected cancers in 13 selected American
countries during 2005–2009 (unless otherwise speciﬁed)
Cancer site
ICD 10
Oral
cavity and
pharynx
Esophagus Stomach Colon
and
rectum
Liver Gallbladder Pancreas Larynx Lung Bone Breast Uterus Ovary Bladder Kidney HL NHL MM Leukemias All
neoplasms
C00–C14 C15 C16 C17–
C21,C26
C22.0–
C22.7
C23–C24 C25 C32 C33–
C34
C40–
C41
C50 C53–
C55
C56–
C57.4
C67 C64–
C66,
C68
C81 C82–
C85, C96
C88,
C90
C91–C95 C00–D48
Argentina 0.71 1.66 3.24 9.55 0.24 2.58 5.66 0.35 8.09 0.53 18.57 9.43 4.08 0.80 1.68 0.26 1.99 0.95 2.93 91.66
222 570 1027 3240 71 785 1888 100 2294 143 5328 2450 1124 306 505 67 598 293 800 27520
Brazil 1.22 1.60 4.32 7.48 0.76 1.78 3.15 0.42 7.14 0.64 11.25 7.80 2.75 0.78 0.88 0.19 1.58 0.99 2.61 73.95
1258 1591 4455 7720 751 1781 3211 413 6992 636 11172 7753 2699 839 871 194 1591 970 2609 74270
Chile 0.47 1.97 8.33 7.62 1.21 11.66 4.59 0.15 7.82 0.50 10.77 7.97 3.40 1.05 1.81 0.19 2.26 1.56 2.75 91.98
59 267 1035 950 138 1302 536 18 890 55 1191 873 358 138 211 20 259 180 289 10656
Colombia 0.98 1.06 8.55 6.46 1.34 2.57 3.11 0.44 7.36 0.55 9.75 9.84 3.33 0.65 0.79 0.26 1.96 0.89 3.24 80.45
209 225 1817 1363 271 523 638 92 1490 118 2036 2076 682 141 161 54 404 174 707 16845
Costa Rica 0.69 0.47 8.49 7.67 1.92 1.60 3.41 0.17 3.41 0.35 11.42 6.73 2.91 0.59 0.88 0.53 2.71 1.39 3.67 74.49
15 11 194 170 42 34 76 4 73 8 247 149 60 14 19 13 59 28 82 1661
Cuba 1.59 1.26 3.06 11.91 0.78 1.05 3.92 1.09 18.43 0.97 14.89 13.10 2.94 1.32 1.05 0.70 2.22 1.36 3.09 99.53
153 119 294 1230 69 97 377 99 1639 76 1306 1104 242 140 90 55 182 124 241 8962
Ecuador 0.58 0.37 10.53 4.17 1.25 2.20 2.54 0.12 3.81 0.66 6.33 11.47 2.09 0.37 0.76 0.24 1.82 0.52 3.04 68.93
38 25 706 278 80 137 161 7 246 43 383 717 128 25 48 16 118 32 202 4443
Mexico 0.58 0.46 4.78 3.97 1.89 2.38 3.53 0.21 4.35 0.54 9.12 9.33 3.29 0.63 1.31 0.33 1.78 0.75 3.28 68.34
304 237 2494 2072 954 1195 1792 108 2238 288 4566 4707 1635 336 652 178 923 362 1759 35042
Puerto Rico
(2005–
2007)
0.62 0.64 2.38 7.82 0.77 0.47 2.66 0.18 6.07 0.39 12.57 4.39 2.94 0.71 0.76 0.15 2.24 1.37 2.15 62.78
24 27 95 303 27 16 103 6 219 11 389 138 95 31 27 5 75 51 71 2201
Uruguay
(2007–
2009)
0.95 1.88 4.12 12.41 0.48 2.87 6.17 0.27 8.18 0.06 19.97 7.90 4.32 1.09 2.33 0.20 2.44 1.51 2.94 99.60
33 72 152 521 15 96 232 10 238 2 602 220 128 51 77 5 86 54 94 3382
Venezuela
(2005–
2007)
0.94 0.60 5.93 5.91 0.85 1.61 3.20 0.43 9.31 0.73 12.22 14.25 3.24 0.74 1.11 0.41 1.92 1.06 2.98 84.20
111 70 693 692 96 181 362 50 1057 87 1435 1712 374 88 128 51 229 118 373 9902
Canada 1.00 1.03 2.01 10.67 1.39 0.80 5.12 0.24 25.40 0.27 15.45 3.67 5.03 1.20 1.71 0.20 3.18 1.59 2.84 97.74
340 383 748 4197 478 300 1881 79 8135 63 4959 1147 1603 540 612 53 1176 590 1004 33553
USA 0.84 0.95 1.48 8.27 1.26 0.66 5.41 0.29 24.38 0.28 15.01 4.40 5.30 1.08 1.63 0.23 2.81 1.59 3.14 93.78
2498 2887 4644 27326 3622 2111 17195 792 69873 599 40762 11433 14786 4145 5027 560 9529 5144 9528 276979
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colon and rectum
In 2005–2009, mortality rates from colorectal cancer in men
were lower than in North America in most Latin American
countries. Rates were below 10.5/100 000, with the exception of
Puerto Rico, Argentina and Uruguay, where rates were about 13,
16 and 19/100 000 men, respectively, compared with 12/100 000
in the USA (Table 1; supplementary Figure S1b, available at
Annals of Oncology online). Less marked differences were regis-
tered in women, for whom most countries had rates between 6.5
and 10/100 000 (Table 2; supplementary Figure S1b, available at
Annals of Oncology online). The lowest female rates (4/100 000)
were in Mexico and the highest in Uruguay and Cuba (12/
100 000 women). Similar patterns were registered in middle-
aged populations (supplementary Tables S1–S2 and Figure S2b,
available at Annals of Oncology online). Colorectal cancer mor-
tality patterns were less favorable in Latin America than in the
USA (for which APC were lower than −2% over the last decade
in both sexes), with even slight but continuous increases during
the last two decades in most countries, with the lowest signiﬁ-
cant APC of 0.3% in Uruguay and the highest APC (∼2%), in
Brazil, Colombia, Ecuador and Puerto Rico (Figure 1; supple-
mentary Table S3, available at Annals of Oncology online).
lung (including trachea, bronchus and lung)
Between 2005 and 2009, lung cancer mortality rates in men
were lower in most Latin American countries than in North
America (39 and 37/100 000 in the USA and Canada, respect-
ively). The highest rates were registered in Uruguay, Cuba and
Argentina (43, 38 and 30/100 000, respectively), whereas the
lowest ones were observed in Ecuador, Costa Rica and Mexico
(6.4, 7.8 and 10/100 000, respectively) (Table 1; supplementary
Figure S1c, available at Annals of Oncology online). In women,
lung cancer mortality rates were below 10/100 000 for all coun-
tries with the exception of Cuba (18/100 000 women). These
rates were appreciably lower than those in the USA and Canada
(∼25/100 000 women) (Table 2; supplementary Figure S1c,
available at Annals of Oncology online). In men, after rises in the
1980s, all countries showed steady, though moderate, decreases
in lung cancer mortality, except Argentina and Ecuador where
the decline started earlier (mid-1980s). Only in Colombia, Cuba
and Venezuela, some increases were registered during the last
decade (APC between 0.5% and 0.8%). Female lung cancer mor-
tality increased over the last three decades, except in Costa Rica
and Mexico, for which a moderate downward trend (APC
∼−2.5%) was evident since the mid-1990s (Figure 1; supple-
mentary Table S3, available at Annals of Oncology online).
breast
The highest breast cancer mortality rates were registered in
Uruguay and Argentina (i.e. 20 and 19/100 000, respectively)
while, in North America (and Cuba), rates were ∼15/100 000. In
most other countries, rates were between 10 and 13/100 000
while, in Colombia, Mexico and Ecuador, rates were below 10/
100 000 (Table 2; supplementary Figure S1d, available at Annals
of Oncology online). Over the last two decades, rates remained
stable in most countries except Brazil, Colombia, Ecuador and
Venezuela for which some rises were evident. In middle-aged
women, slight declines occurred since the early 1990s in
Argentina, Costa Rica, Puerto Rico and Uruguay (Figure 1; sup-
plementary Table S2 and Figure S2d, available at Annals of
Oncology online) with APC lower than −1%. Conversely, in the
USA, breast cancer mortality has been steadily and appreciably
declining, particularly in middle-aged women, over the last two
decades (Figure 1; supplementary Table S3, available at Annals
of Oncology online).
uterus, mainly cervix uteri
Uterine cancer rates remained exceedingly high in Latin
America, particularly in Venezuela, Cuba and Ecuador, with
rates higher than 11/100 000 and 21/100 000 in all-ages and
middle-aged women, respectively (Table 2; supplementary
Table S2, Figures S1d and S2d, available at Annals of Oncology
online). In most other countries, rates were between 7–10/
100 000 in all women and 11–19/100 000 at age 35–64. Only in
Puerto Rico, rates were similar to those registered in the USA
and Canada (about 4 and 7/100 000 in all-ages and in middle-
aged women, respectively). Steady falls were observed since
the 1980s, particularly in middle-aged women, but the extent of
the decline remained limited, particularly in Argentina, Brazil,
Ecuador, Uruguay and Venezuela with APC that remained
around −1.5% (Figure 1; supplementary Table S3, available at
Annals of Oncology online). The distinction between cervix and
corpus uteri is difﬁcult in several countries, since an appreciable
and variable proportion of deaths are registered as ‘uterus,
unspeciﬁed’. Still, when only deaths registered as cervix uteri
were considered, in 2005–2009, the higher rates were in
Venezuela (10/100 000), Mexico (8.0/100 000) and Colombia
(7.7/100 000) (supplementary Table S5, available at Annals of
Oncology online).
prostate
Between 2005 and 2009, Cuba, Uruguay and Venezuela showed
the highest prostate cancer mortality rates (over 18/100 000
overall), while most other countries (i.e. Chile, Argentina, Costa
Rica, Puerto Rico, Colombia and Brazil) had overall rates
between 13 and 17/100 000 (Table 1; supplementary Figure S1d,
available at Annals of Oncology online). Uruguay, Venezuela
and Cuba had also exceedingly high rates in middle-aged men
(8–10/100 000 men) (supplementary Table S1 and Figure S2d,
available at Annals of Oncology online). The lowest rates were in
Ecuador and Mexico, comparable with those of North America, i.
e. ∼10–11/100 000 overall and 4/100 000 in middle age (Table 1;
supplementary Table S1, Figures S1d and S2d, available at Annals
of Oncology online). At all ages, some upward trends were
observed in Cuba and Brazil (APC = 1.4% since 1980 and 1997,
respectively), Colombia and Ecuador (APC of about 1% since
the 1980s), whereas, after the rise in the 1980s, downward trends,
with APC of about −1%, were registered in Argentina, Chile,
Costa Rica and Puerto Rico since 1992 and Mexico since 2002,
for which APC were around −2% (Figure 1; supplementary
Table S3, available at Annals of Oncology online).
Below age 65, no appreciable trends were observed except for
Puerto Rico, Argentina, Colombia and Mexico, where declining
trends were observed (Figure 1; supplementary Table S3, avail-
able at Annals of Oncology online). In the USA, mortality from
prostate cancer has been appreciably declining.
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leukemias
In all countries, mortality from leukemias was comparable
with that of North America in both sexes, with rates in men
between 3.4/100 000 in Brazil and 4.5/100 000 in Uruguay and
∼5/100 000 in Canada and the USA (Table 1; supplementary
Figure S1g, available at Annals of Oncology online). In women,
rates were ∼3/100 000 except in Puerto Rico where the rate was
2.2/100 000 women (Table 2; supplementary Figure S1g, avail-
able at Annals of Oncology online). In the USA, a steady decrease
in mortality from leukemia was observed since the early 1980s,
whereas trends in Latin American countries were less consistent,
with limited declines in Argentina, Chile, Costa Rica, Cuba,
Puerto Rico and Venezuela, and increases in Brazil and Ecuador
(Figure 1; supplementary Table S3, available at Annals of Oncology
online). In Mexico, mortality leveled off in 2002 after two decades
of increase (Figure 1; supplementary Table S3, available at Annals
of Oncology online).
discussion
Over the last decade, total cancer mortality rates remained
comparatively low in most Latin American countries with a few
exceptions, i.e. Uruguay, Cuba, Argentina and Chile, whose rates
are comparable with those of the USA and Canada. Favorable
trends were registered in most countries over the last three decades,
except for Brazil and Cuba, for which unfavorable total cancer
mortality trends were observed. This reﬂects site-speciﬁc unfavor-
able patterns such as breast cancer in Brazil, uterine (cervix) cancer
in Cuba, and prostate and lung cancer in both countries. The falls
in all cancer mortality are more marked in middle-age in all
countries except Brazil, suggesting that further declines are likely
in the near future.
Lung cancer mortality trends essentially reﬂect differences in
the stage and degree of the tobacco epidemic [9]. Even though,
in most Latin American countries, mortality rates continue to
be lower than in the USA, concerns still persist for women,
given recent unfavorable trends in smoking prevalence [10, 11].
The favorable trends in gastric cancer mortality in Latin
America mainly reﬂect better food preservation [12, 13] and, at
least in men, the possible reduction in tobacco smoking [14].
However, mortality from stomach cancer is still comparatively
high in Latin America. This may be due to the high prevalence
of Helicobacter pylori in these countries [15, 16], but also to un-
favorable dietary habits such as high consumption of red and
processed meat and salt [17].
Even if colorectal cancer remained lower in most Latin
American countries than in the USA and Canada, temporal
trends were unfavorable in most countries, probably as a conse-
quence of modiﬁcations in dietary and lifestyle habits. Latin
America is undergoing a nutritional transition with a progres-
sive increase in the prevalence of obesity, with ∼23% of the
population recently classiﬁed overweight or obese [10, 18].
Conversely, in the USA, a marked decrease in colorectal cancer
incidence was registered in both sexes, which largely reﬂects de-
tection and removal of precancerous lesions through colorectal
cancer screening, and improved treatment [19]. Trends in Latin
America indicate that screening, early detection and
management of colorectal cancer remain inadequate in most
areas of the continent.
In most Latin American countries, breast cancer is the leading
cause of cancer death in women, except in Cuba, where lung
cancer is higher [1]. The upward trends in breast cancer mortal-
ity may be partly attributable to changes in reproductive habits
(i.e. reduced number of children [20]), as a consequence of socio-
economic development, but also to geographical differences in
access to screening, early diagnosis and treatment services [21,
22]. Delays in the adoption of adequate prevention plans and
treatments are also the reason for the persisting exceedingly high
mortality rates for cervical cancer in all Latin America [23, 24],
even though a high prevalence of Human papillomavirus remains
a key factor. In Mexico and Costa Rica, the prevalence was esti-
mated to be ∼20% in women with normal cytology [25].
Changes in the diagnosis and certiﬁcation of prostate cancer
may partly explain the upward trends in Latin America, particu-
larly among the elderly. The high rates registered in most Latin
American countries may reﬂect the lack of early detection [26].
The favorable trends observed in some countries (i.e. Chile,
Argentina and Costa Rica) since the late 1990s may reﬂect
improvements in the management of the disease.
No major differences emerged in mortality from leukemias
between Latin and North American countries, even though
trends in Latin America were less favorable. As for prostate
cancer (testicular cancer and Hodgkin’s disease), this suggest
delays in the adoption of modern effective therapeutic schemes,
particularly in the younger population [27].
Integrated cancer prevention campaigns, efﬁcient screening
programs and the access to treatment, whenever effective, con-
tinue to be the critical issues of most Latin American countries
in the 2000s. Even though all the countries considered are clas-
siﬁed as having a high development index (HDI) [28], large in-
equalities persist between and within countries that strongly
affect the availability of health care [27, 29].
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